國家衛生研究院 NHRI:Item 3990099045/10373
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12189/12972 (94%)
造訪人次 : 966911      線上人數 : 742
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/10373


    題名: Verapamil use is associated with reduction of newly diagnosed diabetes mellitus
    作者: Yin, T;Kuo, SC;Chang, YY;Chen, YT;Wang, KK
    貢獻者: Division of Infectious Diseases
    摘要: Objective: The mechanism of the beneficial effect of calcium channel blockers (CCBs), especially verapamil, on the development of type 2 diabetes mellitus (T2DM) has been described. Previous clinical studies aiming to confirm these results were flawed by inappropriate comparator drugs or study designs. This study compared the incidence of T2DM in adults prescribed oral verapamil and propensity score-matched adults prescribed other oral CCBs. Methods: This retrospective population-based cohort study used Taiwan's National Health Insurance Research Database during 2000-2011. T2DM was defined according to the International Classification of Diseases, Ninth Revision, Clinical Modification. Results: During follow-up periods of 41,958 and 42,118 person-years, 269/4930 patients in the verapamil cohort and 340/4930 patients in the matched cohort, respectively, developed T2DM. The incidence rates were 6.41 and 8.07 per 1000 population per year among verapamil and other CCB users, respectively. The adjusted hazard ratio (HR) for T2DM associated with use of verapamil (vs. other CCBs) was 0.80 (95% confidence interval [CI], 0.68-0.94; P = 0.006). After excluding those followed for <180 or <365 days to avoid bias derived from delayed diagnosis, adjusted HRs remained significant (0.79, 95% CI, 0.67-0.93, P = 0.005 and 0.77, 95% CI, 0.65-0.91, P = 0.002, respectively). Only the interaction term for age was significant (P = 0.009). Verapamil had a more prominent effect on those aged > 65 years (P< 0.001). Conclusions: In patients with no known history of DM, oral verapamil use was associated with a decreased incidence of T2DM compared with other CCBs.
    日期: 2017-07
    關聯: Journal of Clinical Endocrinology and Metabolism. 2017 Jul;102(7):2604-2610.
    Link to: http://dx.doi.org/10.1210/jc.2016-3778
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0021-972X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000405621600058
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85023199809
    顯示於類別:[郭書辰] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB28368479.pdf185KbAdobe PDF172檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋